-
Recent Posts
- Babylon Health Applies Artificial Intelligence to Improving Integration of Care and Population Health in Wolverhampton (HTN / RWT / BMJ / Lancet / NHS England)
- Dementia Moonshot Report: Research Priorities and Costs (Alzheimer’s Research UK)
- Dementia-Related Hospital Admissions (BBC News / Alzheimer’s Society)
- NHS Demands Action to Reduce Betting-Related Ill Health (BBC News / NHS England / Respublica)
- Research and Innovation Across the NHS and Academia (BBC News / Academy of Medical Sciences)
Archives
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
Categories
- Antipsychotics
- Assistive Technology
- Charitable Bodies
- Commissioning
- Delirium
- Depression
- Enhancing the Healing Environment
- Falls
- Falls Prevention
- Guidelines
- Hip Fractures
- Housing
- Hypertension
- In the News
- Integrated Care
- International
- Local Interest
- Mental Health
- Models of Dementia Care
- National
- ADASS
- All-Party Parliamentary Group (APPG) on Dementia
- BSI
- CQC: Care Quality Commission
- Department of Health
- Department of Health and Social Care (DHSC)
- Health Education England (HEE)
- Housing LIN
- MAGDR
- Mental Health Foundation
- Mental Health Network (NHS Confederation)
- MHP Health Mandate
- National Audit Office
- National Voices
- NEoLCIN
- NEoLCP
- NHS
- NHS Alliance
- NHS Confederation
- NHS Employers
- NHS England
- NHS Evidence
- NHS Improvement
- NICE Guidelines
- NIHR
- NIHRSDO
- Northern Ireland
- Patients Association
- Public Health England
- RCN
- Royal College of Physicians
- Royal College of Psychiatrists
- SCIE
- Scotland
- UK
- UK NSC
- Wales
- Non-Pharmacological Treatments
- Nutrition
- Pain
- Parkinson's Disease
- Patient Care Pathway
- Person-Centred Care
- Personalisation
- Pharmacological Treatments
- Proposed for Next Newsletter
- Quick Insights
- Standards
- Statistics
- Stroke
- Systematic Reviews
- Telecare
- Telehealth
- Universal Interest
Google Translate (100+ Languages)
Tag Archives: Genomics-Based Medicine
Further £816 Million Invested in NHS / NIHR Biomedical Research Centres (Department of Health)
Summary Extra funding for 20 NHS and university partnerships in England, organized through the National Institute for Health Research (NIHR), has been awarded for research into mental health, dementia and antimicrobial resistance. “Mental health research will see funding increase to … Continue reading →
Posted in Commissioning, Department of Health, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, Local Interest, Mental Health, National, NIHR, Quick Insights, UK, Universal Interest
|
Tagged Barts Health NHS Trust, Barts Health NHS Trust / Queen Mary University of London (NIHR) Biomedical Research Centre, Biomedical Research, Biomedical Research Centres (NIHR), Cambridge University Hospitals NHS Foundation Trust, Cambridge University Hospitals NHS Foundation Trust / University of Cambridge (NIHR) Biomedical Research Centre, Cancer Research in the UK, Central Manchester University Hospitals NHS Foundation Trust, Central Manchester University Hospitals NHS Foundation Trust / University of Manchester (NIHR) Biomedical Research Centre, Dementia Research, Former Health Secretary Jeremy Hunt, Genomics, Genomics and Personalised Medicine, Genomics England, Genomics in the NHS, Genomics-Based Medicine, Great Ormond Street Hospital For Children NHS Foundation Trust, Great Ormond Street Hospital for Children NHS Foundation Trust / University College London (NIHR) Biomedical Research Centre, Guy's and St Thomas' NHS Foundation Trust, Guy’s and St Thomas’ NHS Foundation Trust / King’s College London (NIHR) Biomedical Research Centre, Imperial College Healthcare Trust, Imperial College Healthcare Trust / Imperial College London (NIHR) Biomedical Research Centre, Imperial College London, Infection and Infectious Diseases, Institute of Cancer Research, King’s College London, Leeds Teaching Hospitals NHS Trust, Leeds Teaching Hospitals NHS Trust / University of Leeds (NIHR) Biomedical Research Centre, Mental Health and Illness, Mental Health Research, Mental Health Research Funding, Mental Health Research in NIHR, Moorfields Eye Hospital NHS Foundation Trust, Moorfields Eye Hospital NHS Foundation Trust / University College London (NIHR) Biomedical Research Centre, National Institute for Health Research (NIHR), Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurodegenerative Research, Neurological Disorders, Newcastle University, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne Hospitals NHS Foundation Trust / Newcastle University (NIHR) Biomedical Research Centre, NIHR Biomedical Research Centres, NIHR Clinical Research Network, NIHR Mental Health Research, Nottingham University Hospitals NHS Trust, Nottingham University Hospitals NHS Trust / University of Nottingham (NIHR) Biomedical Research Centre, Oxford Health NHS Foundation Trust, Oxford Health NHS Foundation Trust / University of Oxford (NIHR) Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford University Hospitals NHS Foundation Trust / University of Oxford (NIHR) Biomedical Research Centre, Personalised Medicine, Professor Chris Whitty: Chief Scientific Adviser at Department of Health, Queen Mary University of London, Research and Development, Research and Innovation, Research Commitment, Research Culture, Research Mapping, Research Networks, Research Promotion, Royal Marsden NHS Foundation Trust, Royal Marsden NHS Foundation Trust / Institute of Cancer Research (NIHR) Biomedical Research Centre, Rt Hon Jeremy Hunt MP: Former Secretary of State for Health, Sharing Knowledge and Information, Sheffield Institute for Translational Neuroscience (SITraN), Sheffield Institute for Translational Neuroscience: University of Sheffield, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield Teaching Hospitals NHS Foundation Trust / University of Sheffield (NIHR) Biomedical Research Centre, South London and Maudsley NHS Foundation Trust, South London and Maudsley NHS Foundation Trust / King’s College London (NIHR) Biomedical Research Centre, Translational Neuroscience, Translational Research, University College London, University College London Hospitals NHS Foundation Trust, University College London Hospitals NHS Foundation Trust / University College London (NIHR) Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, University Hospital Southampton NHS Foundation Trust / University of Southampton (NIHR) Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust, University Hospitals Birmingham NHS Foundation Trust / University of Birmingham (NIHR) Biomedical Research Centre, University Hospitals Bristol NHS Foundation Trust, University Hospitals Bristol NHS Foundation Trust / University of Bristol (NIHR) Biomedical Research Centre, University Hospitals of Leicester NHS Trust, University Hospitals of Leicester NHS Trust / University of Leicester (NIHR) Biomedical Research Centre, University of Birmingham, University of Bristol, University of Cambridge, University of Leeds, University of Leicester, University of Manchester, University of Nottingham, University of Oxford, University of Sheffield, University of Southampton
|
Leave a comment
Developments in Dementia Research: From the Horses’ Mouths (NHS England / NIHR)
Summary Professor Alistair Burns (NHS England’s National Clinical Director for Dementia and Older Peoples’ Mental Health), and Professor Martin Rossor (NIHR National Director for Dementia Research), discuss current issues and new approaches in dementia research, touching briefly upon some of … Continue reading →
Posted in For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Mental Health, Models of Dementia Care, National, NHS England, NIHR, Pharmacological Treatments, Quick Insights, UK, Universal Interest
|
Tagged 100000 Genomes Project, A4 Study, Alistair Burns: Honorary Consultant Old Age Psychiatrist in the Manchester Mental Health and Social Care Trust (MMHSCT), Alistair Burns: NHS England’s National Clinical Director for Older People’s Mental Health, Alistair Burns: Professor of Old Age Psychiatry at University of Manchester, Alzheimer's Prevention Initiative, Alzheimer’s Disease Biomarkers, Alzheimer’s Prevention Initiative Study, Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Study (A4 Study), APP and Presenilin, Asymptomatic Alzheimer’s Disease, Banner Alzheimer's Institute, Biomarkers, Chance Genetic Mutations, Colombia, Colombian Alzheimer's Prevention Initiative Registry in Medellín Antioquia, DIAN-TU Study, DIAN-TU Trial, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU), Early Detection of Alzheimer’s Disease, Early Detection of Preclinical Disease, Genentech, Genomics, Genomics England, Genomics in the NHS, Genomics-Based Medicine, Global Outlook, Identification of People At Risk of Dementia, International Collaborations, International Programmes, International Research, Medellin (Colombia), Monoclonal Antibodies, MRC Neurochemical Pharmacology Unit, Mutational Signatures, National Clinical Director for Dementia, National Institute for Health Research (NIHR), National Institutes of Health (NIH), National Institutes of Health (US), Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurodegenerative Research, NIHR Clinical Research Network, NIHR Dementia Translational Research Collaboration, NIHR National Director for Dementia Research, NIHR Translational Research Collaboration, Overcoming Barriers, Participation in Research, Participation in Research Studies, Preclinical Alzheimer's Disease, Presenilin, Prodromal Alzheimer's Disease, Professor Alistair Burns, Professor Martin Rossor: Director of the NIHR Queen Square Dementia Biomedical Research Unit, Professor Martin Rossor: Former Director of the NIHR Dementia and Neurodegenerative Disease Research Network (DeNDRoN), Professor Martin Rossor: Former President of the Association of British Neurologists (2011-2013), Professor Martin Rossor: Honorary Consultant Neurologist at National Hospital for Neurology and Neurosurgery, Professor Martin Rossor: National Hospital (Queen Square), Professor Martin Rossor: NIHR National Director for Dementia Research, Professor Martin Rossor: UCL Institute of Neurology, Promisary Science, Reducing Downstream Effects of Disease, Research and Development, Research and Innovation, Research Commitment, Research Culture, Research Mapping, Research Networks, Research Promotion, Sharing Knowledge and Information, Slowing Progression of Disease (Stabilisation), Solanezumab (Sola or Solab), Solanezumab: Humanised Monoclonal Antibody, Therapeutic Nihilism (Avoiding), Translational Research, UK Genomes Project: Genomics England, University of Southern California’s Alzheimer’s Therapeutic Research Institute, Washington University School of Medicine
|
Leave a comment
The NHS Innovation Accelerator Programme: an Innovation Revolution? (NHS England / BBC News)
Summary The NHS Innovation Accelerator Programme aims to make evidence-based healthcare innovation available to patients. NHS England’s Chief Executive Simon Stevens and National Medical Director Sir Bruce Keogh have announced seventeen successful applicants, in the UK and from abroad, to … Continue reading →
Posted in Assistive Technology, BBC News, Commissioning, For Doctors (mostly), For Researchers (mostly), Health Foundation, In the News, Integrated Care, Local Interest, Management of Condition, Models of Dementia Care, National, NHS, NHS England, Northern Ireland, Person-Centred Care, Personalisation, Quick Insights, Telecare, Telehealth, UK, Universal Interest, Wales
|
Tagged 2015 NHS Innovation Accelerator Fellows, 5YFV: NHS Five Year Forward View, Academic Health Science Networks (AHSNs), Accelerating Innovation, Adopters and Adoption of Innovation, Adoption of Innovations, AHSN Network and UCL Partners, Andrea Howarth: Head of Clinical Services at Congenica (2015 NHS Innovation Accelerator Fellows), Andrea Howarth: IT Platform (2015 NHS Innovation Accelerator Fellows), Andrea Howarth: SAPIENTIA (2015 NHS Innovation Accelerator Fellows), Anna Moore: Model of Care (2015 NHS Innovation Accelerator Fellows), Anne Bruinvels: PxHealthcare (OWise) (2015 NHS Innovation Accelerator Fellows), Anne Bruinvels: Smart Phone App (2015 NHS Innovation Accelerator Fellows), Barriers and Facilitators to Participation, Barriers to Engagement, Barriers to Integration, Barriers to Involvement, Barriers to Joined-Up Care, BBC Health News, Ben Underwood: Smart Phone App (2015 NHS Innovation Accelerator Fellows), Bernadette Porter: Expert Nurse (2015 NHS Innovation Accelerator Fellows), Bernadette Porter: Model of Care (2015 NHS Innovation Accelerator Fellows), Bernadette Porter: NeuroResponse (2015 NHS Innovation Accelerator Fellows), Big Health, Brush DJ, Chronic Obstructive Pulmonary Disease (COPD), Congenica, Data and Digital Health, Deciphering Developmental Disorders (DDD), Dharmesh Kapoor: EPISCISSORS-60 Device (2015 NHS Innovation Accelerator Fellows), Diffusion of Innovation, Diffusion of Innovation Theory, Diffusion Research, Digital Health Innovations, Dr Liz Mear: Chair of AHSN Network, Dr Mahiben Maruthappu: Chairman of the UK Medical Students’ Association (UKMSA), Dr Mahiben Maruthappu: NHS England's NHS Innovation Accelerator (NIA), Economic Sustainability, EpSMon: Epilepsy Self-Management Tool, Expert Nurse Telephone Triage Service, Francis White: AliveCor® Mobile ECG Device (2015 NHS Innovation Accelerator Fellows), Genomics, Genomics and Personalised Medicine, Genomics-Based Medicine, Hardware and Wearables, Health and Care Innovation Expo 2015, Healthcare Pioneers, HealthUnlocked: Peer-to-Peer Social Support Network for Health, i-Thrive, Innovate UK, Innovation, Jo Bibby: Director of Strategy at Health Foundation, Join Dementia Research, Join Dementia Research National Service, Join Dementia Research: Clinical Trials Matchmaker Service, Join Dementia Research: Recruitment Onto Dementia Studies, Lloyd Humphreys: IT Platform (2015 NHS Innovation Accelerator Fellows), Lloyd Humphreys: Patients Know Best (2015 NHS Innovation Accelerator Fellows), Maryanne Mariyaselvam: Non-Injectable Arterial Connector (NIC) Device (2015 NHS Innovation Accelerator Fellows), Matt Jameson Evans: HealthUnlocked Peer-to-Peer Social Support Network (2015 NHS Innovation Accelerator Fellows), Matt Jameson Evans: IT Platform (2015 NHS Innovation Accelerator Fellows), Medical Director of NHS England: Professor Sir Bruce Keogh, Medical Research Council (MRC), National Institute for Health Research (NIHR), Neil Guha: Care Pathway (2015 NHS Innovation Accelerator Fellows), Nervecentre Software, NeuroResponse, New Models of Care, NHS England’s Five Year Forward View, NHS England’s New Models of Care Programme, NHS Five Year Forward View (5YFV), NHS Innovation Accelerator (NIA), NHS Innovation Accelerator (NIA) 2016 Programme, NHS Innovation Accelerator (NIA) 2016 Programme: Early Interventions, NHS Innovation Accelerator (NIA) 2016 Programme: Long-Term Conditions Management, NHS Innovation Accelerator (NIA) 2016 Programme: Management of Long-Term Conditions, NHS Innovation Accelerator (NIA) 2016 Programme: Prevention, NHS Innovation Accelerator (NIA) 2016: Applications Invited, NHS Innovation Accelerator Programme, NHS Innovation Fellowship Scheme, NIA Early Interventions Challenge, NIA Management of Long-term Conditions Challenge, NIA Partners, NIA Partners: East Midlands AHSN, NIA Partners: Eastern AHSN, NIA Partners: Greater Manchester AHSN, NIA Partners: Health innovation Network, NIA Partners: Imperial College Health Partners, NIA Partners: Innovation Agency (North West Coast), NIA Partners: Kent Surrey Sussex AHSN, NIA Partners: UCL Partners, NIA Partners: West Midlands AHSN, NIA Partners: Yorkshire and Humber AHSN, NIA Prevention Challenge, NIA Triple Population Health Challenges, OWise, Participation in Research, Participation in Research Studies, Patient Involvement in Research, Patients Know Best, Paul Volkaerts: IT Platform (2015 NHS Innovation Accelerator Fellows), Paul Volkaerts: Nervecentre Software (2015 NHS Innovation Accelerator Fellows), Penny Newman: Workforce Health Coaching (2015 NHS Innovation Accelerator Fellows), Peter Hames: IT Platform (Big Health Sleepio) (2015 NHS Innovation Accelerator Fellows), Peter Young: PneuX Device (2015 NHS Innovation Accelerator Fellows), Piers Kotting: Process (Join Dementia Research) (2015 NHS Innovation Accelerator Fellows), Pioneers of Quality Improvement, PneuX: Pneumonia Prevention System, Professor Sir Bruce Keogh, Professor Sir David Fish: Managing Director of UCLPartners, Public Involvement in Research, Public Participation in Research, Quality Improvement, Rachel Munton: Chair of AHSNs Network, Research Engagement and Involvement Activities, SAPIENTIA™: Genome Analytics Software, Serenity Integrated Mentoring (SIM): Collaborative Model of Care, Simon Stevens: Chief Executive of NHS England, Sleepio: Digital Sleep Improvement Programme, Sore Throat Test and Treat Service, Spreading Innovation, Sustainability, Tackling Barriers to Innovation, Technology and Innovation, UCL Partners, UCLPartners, University College London, University of Surrey, Ventilator-Associated Pneumonia (VAP), Wearable Devices, Wearable Technology
|
Leave a comment
Eleven Genomics Medicine Centres Planned for England (BBC News / Department of Health / NHS England)
Summary The NHS has announced further steps in a genetics project, which will involve 11 Genomics Medicine Centres being created in English hospitals to gather DNA information. The aim is to support the 100,000 Genomes Project in research towards the … Continue reading →
Posted in Acute Hospitals, BBC News, Commissioning, Department of Health, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, Integrated Care, National, NHS, NHS England, Person-Centred Care, Personalisation, Pharmacological Treatments, Quick Insights, Standards, UK, Universal Interest
|
Tagged 100000 Genome Project: NHS Genomic Medicine Centres, 100000 Genomes Project, Academic Health Science Networks (AHSNs), Advanced Therapies Facility (QEH), Advanced Therapies Facility: Birmingham NIHR / Wellcome Trust Clinical Research Facility (CRF), BBC Health News, Birmingham, Birmingham (UK), Birmingham and the Black Country (Dudley Sandwell Walsall and Wolverhampton), Birmingham CDRC, Birmingham Centre for Clinical Haematology, Birmingham Centre for Clinical Trials (BCCT), Birmingham Children’s Hospital, Birmingham City Council, Birmingham City Deal, Birmingham Experimental Arthritis Treatment Centre for Rheumatoid Arthritis (BEAT-RA), Birmingham Health Partners, Birmingham MRC Centre for Immune Regulation, Birmingham NIHR Liver Biomedical Research Unit (BRU), Cambridge, Cambridge University Hospitals NHS Foundation Trust: Genomics Medicines Centre, Cancer Research UK Centre, Cancer Research UK's Stratified Medicine Programme, Cardiff University’s MRC Centre for Neuropsychiatric Genetics and Genomics (MRC CNGG), Central Manchester University Hospitals NHS Foundation Trust: Genomics Medicines Centre, Centre for Clinical Haematology (CCH), Centre for Endocrinology Diabetes and Metabolism (CEDAM), Centre for Obesity Research, Centre for Translational Inflammation (CTIR), Centre for Translational Inflammation Research (QEH), Chronic Disease Resource Centre (CDRC), City of Sandwell and West Birmingham NHS Foundation Trust, Clinical Research Facility (QEH), Decoding Inherited Disorders, Dementia Research, DNA Extraction, Dudley Group of Hospitals, East of England, East of England NHS GMC: Cambridge University Hospitals NHS Foundation Trust, Exeter, Experimental Cancer Medicine Centre (ECMC), Genetic Disorders and Genomics, Genetic Profiling, Genetic Research, Genetic Susceptibility Loci, Genetic Triggers, Genetic Variants, Genetics of Alzheimer's Disease, Genomic Computing, Genomic Medicine, Genomic Medicine Centres, Genomic Medicine Centres (GMCs), Genomic Technologies, Genomics, Genomics England, Genomics in the NHS, Genomics Medicine Centres, Genomics-Based Medicine, Genotyping, George Freeman: Former Life Sciences Minister, Great Ormond Street Hospital NHS Foundation Trust: Genomics Medicines Centre, Greater Manchester, Greater Manchester NHS GMC: Central Manchester University Hospitals NHS Foundation Trust, Guy's and St Thomas' NHS Foundation Trust: Genomics Medicines Centre London, Health Research Bus (HRB), Health Research Trauma Management Healthcare Technology Co-operative (NIHR Trauma Management HTC), Henry Wellcome Building for Nuclear Magnetic Resonance Facility (HWB-NMR), Herceptin, Human Biomaterials Resource Centre (HBRC), Illumina, Imperial College Health Partners NHS GMC: Imperial College Healthcare NHS Trust, Imperial College Healthcare NHS Trust: Genomics Medicines Centre, Inflammation Research Facility (IRF): NIHR / Wellcome Trust Clinical Research Facility, Innovation, Innovation and Improvement, Innovation in Bioinformatics, Innovation in Biotechnology, Innovation in Genetics, Institute for Translational Medicine in Birmingham, Institute of Translational Medicine (ITM), Institute of Translational Medicine: University of Birmingham, Liverpool Women's NHS Foundation Trust: Genomics Medicines Centre, London, Medical Director of NHS England: Professor Sir Bruce Keogh, Microarrays, MRC ARUK Centre for Healthy Ageing, MRC Centre for Neuropsychiatric Genetics and Genomics (MRC CNGG), Multidisciplinary Assessment of Technology Centre for Healthcare (MATCH), National Institute for Health Research (NIHR), National Institute for Health Research Surgical Reconstruction and Microbiology Research Centre (NIHR SRMRC), Networks, Networks and Alliances, Newcastle upon Tyne Hospitals NHS Foundation Trust: Genomics Medicines Centre, Next-Generation Sequencing (NGS), NHS Five Year Forward View, NHS Five Year Forward View (5YFV), NHS Genomic Medicine Centres, NHS Genomic Medicine Centres Prospectus, NHS Genomics Medicine Centres, NHS Workforce, NIHR / Wellcome Trust Birmingham Clinical Research Facility (WTCRF), NIHR Clinical Research Facility, NIHR Collaborations for Leadership in Applied Health Research and Care for Birmingham and the Black Country (NIHR CLAHRC-BBC), NIHR Horizon Scanning Centre, NIHR Translational Research Partnerships (TRPs), North East, North East and North Cumbria NHS GMC: Newcastle upon Tyne Hospitals NHS Foundation Trust, North West Coast NHS GMC: Liverpool Women’s NHS Foundation Trust, Oxford, Oxford NHS GMC: Oxford University Hospitals Foundation Trust, Oxford University Hospitals Foundation Trust: Genomics Medicines Centre, Partnership, Partnership and Collaboration, Partnership Working, Personalised Medicine, Pharmaceutical Industry, Professor David Adams: Dean of Medicine at University of Birmingham Medical School, Professor Mark Caulfield: Chief Scientist at Genomics England, Professor Sir Bruce Keogh, Professor Sue Hill: Chief Scientific Officer for England, QMM: the Student Magazine of the University of Birmingham College of Medical and Dental Sciences, Queen Elizabeth Hospital, Research and Development, Research and Innovation, Research Commitment, Research Consortia, Research Culture, Research Into Aging, Research Networks, Researcher Access to Data, Resources for Researchers, Royal Devon and Exeter NHS Foundation Trust: Genomics Medicines Centre, Shape of Training Report, Shape Of Training Review, Sir John Chisholm: Executive Chair of Genomics England, South London NHS GMC: Guy’s and St Thomas’ NHS Foundation Trust, South West Peninsula, South West Peninsula NHS GMC: Royal Devon and Exeter NHS Foundation Trust, Southampton, Stem Cell Translational Medicine, STXBP1, Targeted Therapies, Translational Research, UK Genomes Project: Genomics England, UK Research and Life Science Sector, University College London Partners NHS GMC: Great Ormond Street Hospital NHS Foundation Trust, University Hospital Southampton NHS Foundation Trust: Genomics Medicines Centre, University Hospitals Birmingham NHS Foundation Trust, University Hospitals Birmingham NHS Foundation Trust: Genomics Medicines Centre, University Hospitals Birmingham: Cancer Clinical Specialties, University of Birmingham, University of Birmingham Medical School, Wellcome Trust Clinical Research Facility, Wessex NHS GMC: University Hospital Southampton NHS Foundation Trust, West Midlands, West Midlands Academic Health Network, West Midlands NHS GMC: University Hospitals Birmingham NHS Foundation Trust, West Midlands RDS: NIHR Research Design Service (RDS), Whole Genome Sequencing
|
Leave a comment
UK Genomes Project: Genomics England (BBC News / NHS England / HEE / Nature Genetics)
Summary A revolution in medicine is in progress at research centres across the UK, based on unlocking the genetic bases of cancer and other diseases. The UK could become a world leader in genetic research, targeted therapies and personalised medicine. … Continue reading →
Posted in BBC News, Department of Health, Health Education England (HEE), In the News, International, National, NHS, NHS England, Personalisation, Quick Insights, UK, Universal Interest
|
Tagged 100000 Genome Project: NHS Genomic Medicine Centres, 100000 Genomes Project, Aarhus University, Akureyri Hospital (Iceland), Astra Zeneca, BBC Health News, Bioinformatics Research Centre: Aarhus University, Biological Treatments, Biotechnology Companies, Birmingham, Broad Institute / Whitehead Institute (Massachusetts), Bubble-Boy Syndrome (Immune Disorders), Call for Global Moratorium on Clinical Uses of Human Germline Editing, Cambridge, Cambridge University Hospitals NHS Foundation Trust: Genomics Medicines Centre, Cancer Research UK (CRUK), Cas9 (Crispr-Associated Protein 9) Enzyme, Cell and Gene Therapy at Institute of Child Health (ICH), Central Manchester University Hospitals NHS Foundation Trust: Genomics Medicines Centre, Chief Scientific Officer Bulletin, Chief Scientific Officer Bulletin (July 2014), Children's Hospital: Landspitali University Hospital (Reykjavik Iceland), Cleveland Clinic, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Collaborative Projects, Collaborative Working, Crispr, Crispr-Cas9, CRISPR-Cas9 Genome Editing System, Crisprs (Clustered Regularly Interspaced Short Palindromic Repeats), Cross-Sector Partnerships, David Cameron, deCODE Genetics, deCODE Genetics /Amgen Inc., Decoding Inherited Disorders, Dementia Research, Denmark, Department of Human Genetics: University of Leuven, Department of Internal Medicine: Akureyri Hospital (Iceland), Dilated Cardiomyopathy, Division of Cardiovascular Diseases: Mayo Clinic, DNA Extraction, Dr Francis Collins: Director of National Institutes of Health (USA), Dr Marcy Darnovsky: Center for Genetics and Society (USA), Drugs Targeted at Specific Mutations, Duke University, East Anglian Medical Genetics Service: Cambridge University Hospitals NHS Foundation Trust, East of England, East of England NHS GMC: Cambridge University Hospitals NHS Foundation Trust, Elimination of Porcine Endogenous Retroviruses Using Crispr, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Ethical Considerations, Ethical Dilemmas, European Bioinformatics Institute, European Bioinformatics Institute: Wellcome Trust Genome Campus, Exeter, Familial Adenomatous Polyposis (FAP), Foetal Stem Cells, Four Ps of Personalised Medicine: Participatory Role for Patients, Four Ps of Personalised Medicine: Precise Diagnoses, Four Ps of Personalised Medicine: Prediction and Prevention of Disease, Four Ps of Personalised Medicine: Targeted and Personalised Interventions, Francis Crick Institute, Fred and Pamela Buffett Cancer Centre (Omaha), Gene Editing in Mice With Duchenne Muscular Dystrophy, Genetic Disorders and Genomics, Genetic Engineering (Pandora's Box), Genetic Modification of Cells: HIV Treatment Strategy, Genetic Profiling, Genetic Research, Genetic Susceptibility Loci, Genetic Triggers, Genetic Variants, Genetics of Alzheimer's Disease, Genome Campus (Wellcome Trust), Genome Sequencing, Genomic Computing, Genomic Medicine, Genomic Medicine Centres, Genomic Medicine Centres (GMCs), Genomics, Genomics Education Programme, Genomics Education Programme (HEE), Genomics England, Genomics England’s Ethics Advisory Committee, Genomics in the NHS, Genomics-Based Medicine, Genotyping, Germline Alterations (Suggested for DMD Huntington's Disease or Cystic Fibrosis), Germline Editing, Germline Gene Editing, Germline Modification, GM Babies, Great Ormond Street Hospital, Great Ormond Street Hospital (GOSH), Great Ormond Street Hospital NHS Foundation Trust: Genomics Medicines Centre, Greater Manchester, Greater Manchester NHS GMC: Central Manchester University Hospitals NHS Foundation Trust, Guy's and St Thomas' NHS Foundation Trust: Genomics Medicines Centre London, Harvard University, Health Education England's Genomics Education Programme, HEE: Health Education England, Herceptin, Hinxton Group, Housekeeping Proteins, Human Embryos Edited (August 2017), Human Genetic Disorders, Human Germline Editing, Human Protein Atlas, Hypertrophic Cardiomyopathy, IBM Watson Health, IBM's Watson Supercomputer, Iceland, Icelandic Medical Center (Laeknasetrid), IL2RG Gene, Illumina, Imperial College Health Partners NHS GMC: Imperial College Healthcare NHS Trust, Imperial College Healthcare NHS Trust: Genomics Medicines Centre, Improved Prevention Based on Underlying Predisposition, In Utero Stem Cell Therapy, Innovation in Biotechnology, Innovation in Genetics, Innovative Genomics Initiative (University of California in Berkeley / University of California in San Francisco), Institute of Child Health (ICH), International Summit on Human Gene Editing, Introducing Genomics in Healthcare (Health Education England Video), Knowledge Networks, Knowledge Translation, Knut & Alice Wallenberg Foundation, Knut and Alice Wallenberg Foundation, Laboratory in Mjodd (RAM) Iceland, Landscape of Mutations in Breast Cancer Whole-Genome Sequences, Landspitali University Hospital (Iceland), Large DNA Banks, Large-Scale Whole-Genome Sequencing, Large-Scale Whole-Genome Sequencing (Iceland), Liverpool Women's NHS Foundation Trust: Genomics Medicines Centre, London, Lund University, Mayo Clinic (Rochester Minnesota), McDonnell Genome Institute: Washington University (St. Louis), Medical Director of NHS England: Professor Sir Bruce Keogh, Medical Research Council (MRC), Microarrays, Moratorium on Heritable Genome Editing, Mutational Signatures, Mutational Signatures in Breast Cancer, Networks, Networks and Alliances, Newcastle upon Tyne Hospitals NHS Foundation Trust: Genomics Medicines Centre, Next-Generation Sequencing (NGS), NHS Genomic Medicine Centres, NHS Genomic Medicine Centres (NHS GMCs), NHS Genomic Medicine Centres Prospectus, NHS Genomics Medicine Centres, NHS Workforce, North East, North East and North Cumbria NHS GMC: Newcastle upon Tyne Hospitals NHS Foundation Trust, North Thames Genomic Medicine Centre, North Thames NHS Genomic Medicine Centre (NHS GMC), North West Coast NHS GMC: Liverpool Women’s NHS Foundation Trust, North West London Healthcare Trust, Nuffield Council on Bioethics, OHSU Knight Cardiovascular Institute, Osteogenesis Imperfecta, Oxford, Oxford NHS GMC: Oxford University Hospitals Foundation Trust, Oxford University Hospitals Foundation Trust: Genomics Medicines Centre, Partnership, Partnership and Collaboration, Partnership Working, Personalised Health Care for Cancer, Personalised Medicine, Personalised Medicine Strategy (NHS England), Personalised Medicine Strategy Board, Personalised Medicine Strategy for the NHS, Personalised Medicine: Improving Outcomes, Peter Grainger: Patient and Public Involvement Representative at St Mark’s Hospital (North West London Healthcare Trust), Pharmaceutical Industry, PHG Foundation, Prof Peter Braude: King's College London, Professor Ian Cumming OBE: HEE Chief Executive, Professor Sir Bruce Keogh, Professor Sue Hill: Chief Scientific Officer for England, Profiling Individual Cancer Genomes (Personalised Medicine), Protein-Coding Cancer Genes, Radboud University, Regional Genetic Laboratories, Research and Development, Research and Innovation, Research Commitment, Research Consortia, Research Culture, Research Into Aging, Research Networks, Researcher Access to Data, Resources for Researchers, Royal Devon and Exeter NHS Foundation Trust: Genomics Medicines Centre, Royal Institute of Technology in Sweden, Sanger Institute, School of Engineering and Natural Sciences, Science Working Group: Cancer, Science Working Group: Infectious Diseases, Science Working Group: Rare Diseases, Small and Medium Enterprises (SMEs), SMEs, Somatic Genetic Basis of Breast Cancer, South London NHS GMC: Guy’s and St Thomas’ NHS Foundation Trust, South West Peninsula, South West Peninsula NHS GMC: Royal Devon and Exeter NHS Foundation Trust, Southampton, St Mark’s Hospital, Sun Yat-sen University in Guangdong (China), Talens, Targeted Drugs, Targeted Therapies, Testes, Thermo Fisher Scientific (Massachusetts), Transformational Elements of NHS Genomic Medicine Centres, UK Genomes Project: Genomics England, UK Research and Life Science Sector, University College London Partners NHS GMC: Great Ormond Street Hospital NHS Foundation Trust, University Hospital Southampton NHS Foundation Trust: Genomics Medicines Centre, University Hospitals Birmingham NHS Foundation Trust: Genomics Medicines Centre, University of Iceland, University of Texas MD Anderson Cancer Center, USA, Viv Parry OBE (Science Broadcaster), Wellcome Trust, Wellcome Trust Sanger Institute, Wessex NHS GMC: University Hospital Southampton NHS Foundation Trust, West Midlands, West Midlands NHS GMC: University Hospitals Birmingham NHS Foundation Trust, Whole Genome Sequencing, Workforce Competencies, Workforce Development, Workforce Training, Xenotransplantation: Avoiding Shortage of Human Donor Organs, Yale Cancer Centre, Zinc fingers
|
Leave a comment
